Inborn disorder of bilirubin metabolism
MONDO:0017755An instance of bilirubin metabolism disease that is caused by an inherited modification of the individual's genome.
Also known as: disorder of bilirubin metabolism, disorder of bilirubin metabolism and excretion, hereditary bilirubin metabolism disease, inborn disorder of bilirubin metabolism and excretion, bilirubin metabolism disorder
39 clinical trials for this condition and its sub-types, 0 tagged with Inborn disorder of bilirubin metabolism itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Inborn disorder of bilirubin metabolism
-
Hereditary hyperbilirubinemia 0 trials · 18 incl. sub-types
7 sub-types
- Transient familial neonatal hyperbilirubinemia 18 trials
- Crigler-Najjar syndrome 0 trials Sub-types →
- Dubin-Johnson syndrome 0 trials
- Gilbert syndrome 0 trials
- Rotor syndrome 0 trials
- Hyperbilirubinemia, conjugated, type 3 0 trials
- Hyperbilirubinemia, shunt, primary 0 trials
-
Progressive familial intrahepatic cholestasis 16 trials · 17 incl. sub-types
16 sub-types
- Progressive familial intrahepatic cholestasis type 1 4 trials
- Progressive familial intrahepatic cholestasis type 2 4 trials
- Cholestasis, progressive familial intrahepatic, 4 2 trials
- Progressive familial intrahepatic cholestasis type 3 2 trials
- Cholestasis, progressive familial intrahepatic, 5 1 trial
- Cholestasis, progressive familial intrahepatic, 6 1 trial
- Hereditary North American Indian childhood cirrhosis 1 trial
- MYO5B-related progressive familial intrahepatic cholestasis 0 trials
- Benign recurrent intrahepatic cholestasis type 1 0 trials
- Cholestasis, progressive familial intrahepatic, 10 0 trials
- Cholestasis, progressive familial intrahepatic, 11 0 trials
- Cholestasis, progressive familial intrahepatic, 12 0 trials
- Cholestasis, progressive familial intrahepatic, 13 0 trials
- Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss 0 trials
- Cholestasis, progressive familial intrahepatic, 8 0 trials
- Cholestasis, progressive familial intrahepatic, 9 0 trials
-
Benign recurrent intrahepatic cholestasis 2 trials · 5 incl. sub-types
2 sub-types
- Benign recurrent intrahepatic cholestasis type 2 0 trials · 4 incl. sub-types Sub-types →
- Benign recurrent intrahepatic cholestasis type 1 0 trials
-
Bilirubin encephalopathy 3 trials
1 sub-type
- Kernicterus due to isoimmunization 0 trials
-
2 sub-types
Most studied deeper sub-types
-
Could zinc and a liver pill help newborns beat jaundice faster?
Disease control CompletedThis study tests whether giving oral zinc sulfate and ursodeoxycholic acid alongside standard light therapy can help clear jaundice faster in newborns. About 80 babies with non-hemolytic jaundice will receive one of two doses of zinc, or the liver drug UDCA, plus phototherapy. Th…
Phase 4 • Sponsor: Amira Adel Fouly • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Promising long-term results for rare liver disease drug in kids
Disease control CompletedThis study looked at the long-term safety and effectiveness of a drug called A4250 (odevixibat) in 116 children with progressive familial intrahepatic cholestasis (PFIC), a rare liver disease. The children took the drug for up to 72 weeks. The study measured changes in bile acid …
Phase 3 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Hope for rare liver disease: drug aims to ease severe itching in children
Disease control CompletedThis study tests the long-term safety of maralixibat, an oral medication, in children with progressive familial intrahepatic cholestasis (PFIC), a rare liver disease that causes intense itching. Participants who completed a prior study will receive maralixibat twice daily. Resear…
Phase 3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug shows promise for babies with rare liver disorders
Disease control CompletedThis study tested the safety of a drug called maralixibat in 27 infants under 12 months old with Alagille syndrome or progressive familial intrahepatic cholestasis (PFIC), two rare liver diseases that cause bile buildup. The drug is given as an oral solution and aims to reduce bi…
Phase 2 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Liver drug maralixibat tested for Long-Term safety in rare disease patients
Disease control CompletedThis study looked at the long-term safety of a drug called maralixibat in 52 people with cholestatic liver disease, including Alagille Syndrome and other rare conditions. Participants had already taken maralixibat in an earlier study. Researchers tracked side effects and how well…
Phase 2 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug shows promise for rare childhood liver disease
Disease control CompletedThis study tested a drug called odevixibat (A4250) in 62 children with progressive familial intrahepatic cholestasis (PFIC) types 1 and 2, a rare liver disease that causes severe itching and bile buildup. The drug works by blocking the reabsorption of bile acids in the gut. The g…
Phase 3 • Sponsor: Albireo • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a $10 ruler save newborns from brain damage?
Diagnosis CompletedThis study tested a simple, low-cost plastic ruler called the Bili-ruler to screen newborns for jaundice. Over 4,000 infants were checked with the ruler, a standard device, and visual inspection. The goal was to see if the ruler can accurately identify dangerous jaundice, especia…
Sponsor: George Washington University • Aim: Diagnosis
Last updated Jun 27, 2026 12:39 UTC
-
Kitchen foil vs bed sheet: which boosts jaundice treatment best?
Symptom relief CompletedThis study tested whether adding reflective materials like aluminum foil or white cloth around babies during light therapy for jaundice helps lower bilirubin faster. 81 newborns with mild jaundice were randomly assigned to standard therapy, therapy with white cloth reflectors, or…
Sponsor: Kubra Nur Kabakcı Sarıdağ • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Simple cover and massage may speed up jaundice treatment in newborns
Symptom relief CompletedThis study looked at whether placing a white cover over the incubator and giving gentle massage during phototherapy can lower bilirubin levels faster in newborns with jaundice caused by ABO incompatibility. Sixty full-term babies were included. The goal was to see if these simple…
Sponsor: Karabuk University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New drug shows promise for rare liver disease itch
Symptom relief CompletedThis study tested a drug called TAK-625 (maralixibat) in 5 Japanese children with progressive familial intrahepatic cholestasis (PFIC), a rare liver disease that causes severe itching. The main goal was to see if the drug reduces itching over 26 weeks. Researchers also checked sa…
Phase 3 • Sponsor: Takeda • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Simple cover and massage may speed up jaundice treatment in newborns
Symptom relief CompletedThis study looked at whether covering the incubator with a white cover and giving baby massage during phototherapy can lower bilirubin levels and shorten treatment time in newborns with jaundice. Researchers studied 60 full-term babies receiving phototherapy. The goal was to see …
Sponsor: Karabuk University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Simple drape may help newborns beat jaundice faster
Symptom relief CompletedThis study tested whether placing a white reflective drape around phototherapy lights helps lower bilirubin levels faster in newborns with jaundice. 102 babies received either standard phototherapy or phototherapy with the drape. Researchers measured bilirubin at 4 and 24 hours a…
Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Jun 26, 2026 17:12 UTC
-
Spanish study hunts for hidden liver disease genes
Knowledge-focused CompletedThis study looks for genetic changes linked to progressive familial intrahepatic cholestasis (PFIC) in adults with unexplained bile flow problems. Researchers will collect health information and blood samples from 150 participants across Spain during a single visit. The goal is t…
Sponsor: Ipsen • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Motivation model may sharpen nursing Students' heart exam skills
Knowledge-focused CompletedThis study tests whether a teaching approach called ARCS (Attention, Relevance, Confidence, Satisfaction) can improve nursing students' ability to perform cardiovascular physical exams. One hundred second-year nursing students will receive either standard training or standard tra…
Sponsor: Cumhuriyet University • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Cord clamping delay may boost jaundice risk in At-Risk newborns
Knowledge-focused CompletedThis study looked at whether waiting 60 seconds to clamp the umbilical cord (delayed cord clamping) raises bilirubin levels in newborns whose mothers had a previous child with jaundice needing treatment. Twenty mothers and their babies took part. The goal was to see if delayed cl…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Parents track newborn jaundice at home in massive study
Knowledge-focused CompletedThis completed observational study involved over 220,000 healthy newborns across China. Parents used a handheld device to measure jaundice levels by shining light through the skin from birth to 30 days old. The goal was to create a standard chart of normal bilirubin levels to hel…
Sponsor: Neonatal-Infant Brain and Behavior Development Network • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:25 UTC